Gilles Cauet

Title: Gilles Cauet: Innovator in Basic Fibroblast Growth Factor Research

Introduction

Gilles Cauet is a notable inventor based in Buccinasco, Italy. He has made significant contributions to the field of biotechnology, particularly in the area of basic fibroblast growth factor (bFGF). His work focuses on the production of derivatives of bFGF, which have important implications in the angiogenic process.

Latest Patents

Cauet holds a patent for a "Deletion mutant of basic fibroblast growth factor and production thereof." This invention relates to the production of bFGF derivatives using recombinant DNA techniques. These derivatives can function as antagonists and/or superagonists of the wild type molecule, enhancing our understanding of angiogenesis. The production process involves transforming strains of E. coli with plasmids that carry the nucleotide sequences coding for human and bovine bFGF and their derivatives. He has 1 patent to his name.

Career Highlights

Gilles Cauet is associated with Farmitalia Carlo Erba S.r.l., a company known for its innovative approaches in the pharmaceutical industry. His work at the company has allowed him to explore the potential of bFGF derivatives in medical applications.

Collaborations

Cauet has collaborated with notable colleagues, including Laura Bergonzoni and Antonella Isacchi. These partnerships have contributed to the advancement of research in the field of fibroblast growth factors.

Conclusion

Gilles Cauet's innovative work in the production of bFGF derivatives showcases his commitment to advancing biotechnology. His contributions have the potential to impact various medical applications significantly.